A Study of AGEN2034 in Advanced Tumors and Cervical Cancer

NCT03104699 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

211

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
Cervical Cancer

Interventions

DRUG: AGEN2034

Sponsor

Agenus Inc.